You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MRNA Sale Disclosure
Bancel Stephane · SEC Form 4 · Filed Aug 7, 2026
Sale
Calculated transaction value
$2.32M
Bancel Stephane Chief Executive Officer
MRNA
Moderna
MRNA
Transaction date
Aug 5, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 2 days later
MRNA daily price context
Close on/before transaction
$56.26
Aug 5, 2026
First close after public filing
$59.81
Aug 10, 2026
30-day return after filing
+134.63%
Through Sep 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 39,891 shares @ $58.12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001682852-26-000153
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$43.11M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Aug 6, 2026 | $4.83M |
| Moderna, Inc. MRNA | Exercise | Aug 6, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Aug 6, 2026 | $0 |
| Moderna, Inc. MRNA | Sale | Aug 5, 2026 | $7.11M |
| Moderna, Inc. MRNA Current | Sale | Aug 5, 2026 | $2.32M |
| Moderna, Inc. MRNA | Exercise | Aug 5, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Aug 5, 2026 | $0 |
| Moderna, Inc. MRNA | Sale | Aug 5, 2026 | $11M |
| Moderna, Inc. MRNA | Exercise | Aug 5, 2026 | $9.56M |
| Moderna, Inc. MRNA | Sale | Aug 5, 2026 | $8.29M |